Encephalitis Clinical Trials in Paris
5 recruitingParis, France
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
NMDAR Autoimmune EncephalitisLGI1 Autoimmune Encephalitis
Hoffmann-La Roche152 enrolled93 locationsNCT05503264
Recruiting
Not Applicable
High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network
Acute Disseminated EncephalomyelitisEncephalitis Autoimmune
University Hospital, Angers20 enrolled8 locationsNCT06863974
Recruiting
Not Applicable
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism
Autoimmune Encephalitis
Assistance Publique - Hôpitaux de Paris56 enrolled1 locationNCT06079294
Recruiting
Not Applicable
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis
Hospices Civils de Lyon3,500 enrolled62 locationsNCT05198661
Recruiting
Phase 2
Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis
Anti-NMDAR Encephalitis
Assistance Publique - Hôpitaux de Paris20 enrolled1 locationNCT03274375